All recall categories

Prescription and over-the-counter medication recalls

Drug recalls come from the FDA's drug enforcement reports. They range from a wrong label to a product that could be harmful, and the risk level on each notice is the FDA's own classification. Never stop a prescribed medication on the strength of a recall notice alone — the notice will say whether to return it, and your prescriber or pharmacist decides what replaces it.

4,524 stored notices, reported between Jun 20, 2012 and Oct 28, 2026. Newest first.

Drugs

Reported Oct 28, 2026Updated Nov 2, 2026

Amlodipine and Olmesartan Medoxomil Tablets, 10mg/40mg, 30 Tablets, Rx only, Manufactured by: Alkem Laboratories Ltd.,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Ascend Laboratories, LLC

FDA (openFDA drug enforcement)

Drugs

Reported Oct 28, 2026Updated Nov 2, 2026

Glutathione Injection (Glutathione-L, Ascorbic Acid, Sodium Hydroxide, Bacteriostatic Water), 200 mg/mL, 10 mL…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Greenwich Rx

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 28, 2026Updated Nov 2, 2026

Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Hikma Pharmaceuticals USA Inc.

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 28, 2026Updated Nov 2, 2026

Argatroban Injection, USP, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Manufactured for: Endo USA,…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Par Health USA, LLC

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 28, 2026Updated Nov 2, 2026

Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc.,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Pfizer

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 28, 2026Updated Nov 2, 2026

Brush Buddies, Mint Chocolate Chip Ice Cream Flavored Toothpaste, Anticavity Fluoride Toothpaste, (sodium fluoride…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Pritam International Private Limited

2 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 28, 2026Updated Nov 2, 2026

Testosterone Cypionate, 200 mg/mL, packaged in a) 5 mL vials (NDC 73271-1225-1) and b) 30 m vials ( NDC 73271-1226-2)…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Right Value Drug Stores LLC

FDA (openFDA drug enforcement)

Drugs

Reported Oct 28, 2026Updated Nov 2, 2026

Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Shenzhen Techdow Pharmaceutical Co., Ltd.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 28, 2026Updated Nov 2, 2026

Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, 605 014,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Strides Pharma Inc.

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 28, 2026Updated Nov 2, 2026

Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: Mylan Pharmaceuticals…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Viatris, Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 21, 2026Updated Oct 26, 2026

Metoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only, Distributed by: American Health Packaging, Columbus,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

American Health Packaging

FDA (openFDA drug enforcement)

Drugs

Reported Oct 21, 2026Updated Oct 26, 2026

Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Houston Rx LLC

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 21, 2026Updated Oct 26, 2026

Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Teva Pharmaceuticals USA, Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 21, 2026Updated Oct 26, 2026

Hydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, Rx Only, Manufactured by: Zydus Lifesciences…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Zydus Pharmaceuticals (USA) Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 14, 2026Updated Oct 20, 2026

Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Apothecary Pharma LLC

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 14, 2026Updated Oct 20, 2026

Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

BioSpectra, Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 14, 2026Updated Oct 20, 2026

QUAD-MIX( PAPAV/PHENTO/ALPROS/TROP) INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Carolina Infusion, LLC

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 14, 2026Updated Oct 20, 2026

Tri-Immune Boost (Glutathione: 200 mg, Ascorbic Acid: 200 mg, Zinc: 2.5 mg), 30 mL vial, Rx only, Centric Compounding,…

Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.

Centric Compounding LLC

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 14, 2026Updated Oct 20, 2026

Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Cipla USA, Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 14, 2026Updated Oct 20, 2026

IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

J&j Innovative Medicine

FDA (openFDA drug enforcement)

Drugs

Reported Oct 14, 2026Updated Oct 20, 2026

Artificial Tears Sterile Lubricant Eye Drops (polyvinyl alcohol 0.5%, povidone 0.6%), 0.5 FL OZ (15 mL) bottles; a)…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

K.C. Pharmaceuticals, Inc.

6 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 14, 2026Updated Oct 20, 2026

Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A.,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Preferred Pharmaceuticals, Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Oct 14, 2026Updated Oct 20, 2026

Tretinoin Cream USP, 0.05%, 45 g tube, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Taro…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Sun Pharmaceutical Industries Inc.

2 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 7, 2026Updated Oct 13, 2026

Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Ajanta Pharma USA Inc.

FDA (openFDA drug enforcement)

Free recall alerts

Get alerted about new Medication recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Related categories

RecallNow is not a government agency. Every notice above was published by the FDA, USDA FSIS or CPSC and links back to its source. Browse the whole archive.